The Company holds agreements related to the commercialization and licensing of aldoxorubicin, including a Royalty Agreement and a First Amendment with XOMA. It may either commercialize aldoxorubicin directly or license it to third parties, with royalty and milestone payments made to XOMA as stipulated. The Company entered into a Mutual Termination and Release Agreement with NantCell, ImmunityBio, and XOMA, terminating a prior License Agreement and addressing the potential purchase of aldoxorubicin inventory for global research, development, and commercialization. Additionally, the Company sold rights to its molecular chaperone assets, arimoclomol and iroxanadine, to Orphazyme A/S, receiving upfront and milestone payments. Customers and markets associated with the Company include ImmunityBio, NantCell, Orphazyme A/S, and XOMA.
Ladrx’s Comment on Sales, Marketing and Customers
The Company holds agreements related to the commercialization and licensing of aldoxorubicin, including a Royalty Agreement and a First Amendment with XOMA. It may either commercialize aldoxorubicin directly or license it to third parties, with royalty and milestone payments made to XOMA as stipulated. The Company entered into a Mutual Termination and Release Agreement with NantCell, ImmunityBio, and XOMA, terminating a prior License Agreement and addressing the potential purchase of aldoxorubicin inventory for global research, development, and commercialization. Additionally, the Company sold rights to its molecular chaperone assets, arimoclomol and iroxanadine, to Orphazyme A/S, receiving upfront and milestone payments. Customers and markets associated with the Company include ImmunityBio, NantCell, Orphazyme A/S, and XOMA.
Sources:
Ladrx Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Ladrx Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Ladrx Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
